You are on page 1of 23

JWT

JWT is one of the largest advertising agencies in the United States and the fourthlargest in the world. It is one of the key companies of Sir Martin Sorrell's WPP Group (NASDAQ:WPPGY) and is headquartered in New York. The global agency is led by Worldwide Chairman and Global CEO Bob Jeffrey who took over the role in 1998. [1] JWT was named Adweek magazine's 2009 "Global Agency of the Year."[History The company that was to become JWT was founded by William James Carlton in 1864. Carlton's company was renamed by James Walter Thompson in 1877 to The James Walter Thompson Company, which eventually became J. Walter Thompson. It was acquired by WPP Group in 1987. In 2005, the agency was "relaunched" by dropping the name J. Walter Thompson in exchange for JWT.[3] JWT claims to be the first to:
 

build the first full-service advertising agency[4] create the first international network. Its London office opened in 1899.[5] By 1930, the agency had established offices in some 30 countries. pioneer ad careers for women. It hired the first female creative director in 1908.[6][7] create the first-ever testimonial ad (it was for Pond's Cold Cream), in 1925.[8][9] invent the grilled cheese sandwich for its client Kraft[10] in 1930. produce the first-ever TV commercial in 1939. develop account planning in 1968. Stephen King is considered the father of account planning.[11] create the first advertisement in Second Life (Ford Argentina)[12] be the first agency to create its own television Christmas special in 2009, Macy's "Yes, Virginia" (JWT New York)[13]

    

 

[edit]Business JWT's network has nearly 10,000 employees in more than 200 offices in over 90 countries, who serve over 1,200 clients. Clients of JWT include:
  

Bayer Bloomberg[14] Energizer

              

HSBC Johnson & Johnson Kimberly-Clark Kraft Macy's Nestlé Nokia Rolex Royal Caribbean Shell Tim Hortons Unilever United States Marine Corps U.S. Corp. for Travel Promotion[15] Transamerica

[edit]JWT New York JWT New York is the headquarters of JWT Worldwide[16] as well as the largest of JWT’s 200-plus offices, serving clients like Bloomberg, Cadbury, Diageo, HSBC, Johnson & Johnson, Nestlé, Royal Caribbean, Schick, U.S. Corp. for Travel Promotion among others. In March 2010, David Eastman was named CEO JWT North America.[17] He is also the worldwide digital director for JWT. Eastman's first acquisition was the fullservice, award-winning digital shop Digitaria. The San-Diego based agency was acquired in August 2010.[18] In July 2011, Eastman also acquired the Los Angeles-based shopper marketing firm Lunchbox. [19] In August 2011, JWT New York won the U.S. Corp. for Travel Promotion account.[20]The New York offices of JWT were designed by Clive Wilkinson Architects. [edit]JWT INSIDE JWT INSIDE provides organizations with advertising, marketing and employee communications services. Measurement tools, consulting resources and strategic approaches are employed to put people in jobs and keep the workforce engaged. The

agency has 11 locations offices across North America and internationally. It is a subsidiary of JWT. Its parent company is WPP. [edit]JWT Atlanta JWT Atlanta is a top 10 office in the JWT network and services a roster of clients including the United States Marine Corps, the U.S. Virgin Islands, Transamerica, Shell, Jiffy Lube and FEMA, among others. With offices in Atlanta, Dallas and Houston, JWT Atlanta provides fully integrated engagement services, including creative development, planning, digital strategy, social media, media planning and buying, UX, website design/development, search and analytics. Today, the full-service Atlanta office is led by Rob Quish, a member of JWT North America’s management team and CEO of JWT INSIDE

Bayer From Wikipedia, the free encyclopedia This article is about the chemical and pharmaceutical company. For other uses, see Bayer (disambiguation). Not to be confused with Beyer (disambiguation). Bayer AG

Type Traded as

Aktiengesellschaft FWB: BAYN

Industry Pharmaceuticals, chemicals Founded 1863 Founder( Friedrich Bayer, Johann s) Friedrich Weskott Headqua Leverkusen, Germany rters Key people Marijn Dekkers (CEO), Manfred Schneider (Chairman of thesupervisory board)

Products Veterinary drugs, diagnostic imaging, general and specialtymedicines, women's healthproducts, over-thecounter drugs, diabetes care, pesticide s,plant biotechnology, polymers,coatin gs, adhesives Revenue €35.09 billion (2010)[1] Operatin €2.730 billion (2010)[1] g income Profit Total assets €1.301 billion (2010)[1] €51.51 billion (end 2010)[1]

Total equity

€18.90 billion (end 2010)[1]

Employe 111,400 (FTE, 2010)[1] es Subsidia Bayer MaterialScience, Bayer ries USA, Bayer Schering Pharma,Bayer HealthCare Pharmaceuticals, Bayer CropScience Website www.bayer.com

Bayer AG (German pronunciation: [ˈbaɪɐ]) is a chemical and pharmaceutical company founded in Barmen (today a part of Wuppertal), Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin.

History

Advertisement for Aspirin,Heroin, Lycetol and Salophen

Bayer AG was founded in Barmen (today a part of Wuppertal), Germany in 1863 by Friedrich Bayer and his partner, Johann Friedrich Weskott. Bayer's first major product was acetylsalicylic acid (originally discovered by French chemist Charles Frederic Gerhardt in 1853), a modification of salicylic acid orsalicin, a folk remedy found in the bark of the willow plant. By 1899, Bayer's trademark Aspirin was registered worldwide for Bayer's brand of acetylsalicylic acid, but because of the confiscation of Bayer's US assets and trademarks during World War I by the United States - and the subsequent widespread usage of the word to describe all brands of the compound, "Aspirin" lost its trademark status in the United States, France, and the United Kingdom. It is now widely used in the US, UK, and France for all brands of the drug. However in over 80 other countries, such as Canada, Mexico, Germany, and Switzerland, it is still a registered trademark of Bayer. In 1904, the Bayer company introduced the Bayer cross as its corporate logo. Because Bayer's aspirin was sold through pharmacists and doctors only, and the company could not put its own packaging on the drug, the Bayer cross was imprinted on the actual tablets, so that customers would associate Bayer with its aspirin.[citation needed] As part of the reparations after World War I, assets of the Bayer company, including the rights to its name and trademarks, were confiscated in the United States, Canada, and several other countries. In the United States and Canada, Bayer's assets and trademarks were acquired by Sterling Drug, a predecessor of Sterling Winthrop. The Bayer company then became part of IG Farben, a conglomerate of German chemical industries that formed a part of the financial core of the German Nazi regime. IG Farben owned 42.5% of the company that manufactured Zyklon B,[2] a chemical used in the gas chambers of Auschwitz and other extermination camps. During World War II, the company also extensively used slave labor in factories attached to large slave labor camps, notably the sub-camps of the Mauthausen-Gusen concentration camp.[3] When the Alliessplit IG Farben into several pieces after World War II for involvement in organized Nazi war crimes, Bayer reappeared as an individual business. The Bayer executive Fritz ter Meer, sentenced to seven years in prison by the Nuremberg War Crimes Tribunal, was made head of the supervisory board of Bayer in 1956, after his release.[4] In 1978, Bayer purchased Miles Laboratories and its subsidiaries Miles Canada and Cutter Laboratories (along with a product line including AlkaSeltzer, Flintstones vitamins and One-A-Day vitamins, and Cutter insect repellent). In

1994, Bayer AG purchased Sterling Winthrop's over-the-counter drug business from SmithKline Beecham and merged it with Miles Laboratories, thereby reacquiring the U.S. and Canadian trademark rights to "Bayer" and the Bayer cross, as well as the ownership of the Aspirin trademark in Canada. On November 2, 2010, Bayer AG signed an agreement to buy Auckland-based animal health company Bomac Group. Due to confidentiality obligations, no financial information was disclosed.[5]

Bayer Heroin bottle Bayer has discovered, among others:

Aspirin, an analgesic, antipyretic, and anticoagulant medicine, arguably was the most commercially successful drug ever. Heroin (diacetylmorphine) — an addictive drug, was originally sold as a cough treatment. Heroin was a Bayer trademark, until World War I. Prontosil was the first sulfonamide. Ciprofloxacin is an antibiotic used to treat anthrax and urinary tract infections. Levitra is a treatment for erectile dysfunction. Polyurethane is a very versatile polymer used for a wide variety of applications Polycarbonate is the material used in plasic products, CDs, for example (Makrolon). Suramin

     

  

Parathion — insecticide Propoxur — insecticide Primodos — hormone pregnancy testing

[edit]Logo The company's corporate logo, the Bayer cross, was introduced in 1904. It consists of the horizontal word "BAYER" crossed with the vertical word "BAYER", both words sharing the "Y", and enclosed in a circle. An illuminated version of the logo lights up the skyline of Leverkusen, where Bayer is headquartered. Installed in 1958, this is the largest illuminated advertisement in the world. [edit]Operations

Werner Wenning (Chairman of the Board of Management until October 2010) To separate operational and strategic managements, Bayer AG was reorganized into a holding company in December 2003. The group's core businesses were transformed into limited companies, each controlled by Bayer AG. These companies are: Bayer CropScience AG; Bayer HealthCare AG; Bayer MaterialScience AG and Bayer Chemicals AG, and the three service limited companies Bayer Technology Services GmbH, Bayer Business Services GmbH and Bayer Industry Services GmbH & Co. OHG. Following the reorganization, its chemicals activities (with the exception of H.C. Starck and Wolff Walsrode) were combined with certain components of the polymers segment to form the new company Lanxess on July 1, 2004. Lanxess was listed on the Frankfurt Stock Exchange in early 2005. Bayer HealthCare's Diagnostics Division was acquired by Siemens Medical Solutions in January 2007.

Bayer AG shares are listed on the Frankfurt Stock Exchange, the London Stock Exchange and previously on the New York Stock Exchange. Bayer is governed by a board of management, consisting of: Klaus Kühn, Wolfgang Plischke, Richard Pott, and Marijn Dekkers.[6] In 2004, Bayer HealthCare AG acquired the over-the-counter (OTC) Pharmaceutical Division of Roche Pharmaceuticals. On March 13, 2006, Merck KGaA announced a €14.6bn bid for Schering AG. Merck's takeover bid was surpassed by Bayer's $19.5bn bid on March 23, 2006. On March 11, 2008, Bayer HealthCare announced an agreement to acquire the portfolio and OTC division of privately owned Sagmel, Inc., a US-based company that markets OTC medications in most of the Commonwealth of Independent States countries such as Russia, Ukraine, Kazakhstan, Belarus, and others.[7][8] [edit]Locations

Germany - headquarters of the holding company, as well as the subsidiary companies Bayer CropScience, Bayer MaterialScience and Bayer HealthCare Belgium - including production facilities for Makrolon and polyurethanes (in Antwerp)

 Canada - Toronto headquarters and offices in Montreal and Calgary

France - including European headquarters of Bayer CropScience (in Lyon)

 Italy - including five production facilities

The Netherlands - including eight facilities and subsidiaries with 600 employees in three different sectors; Marketing and Sales, Production and Research. Philippines - including production of Canesten, Autan and Baygon United States - Bayer USA operates a suburban Pittsburgh headquarters.

 

 United Kingdom - Newbury Berkshire
     

Australia Argentina Aruba Bahamas Barbados Bolivia

     

Finland Guatemala Honduras Hong Kong SAR Hungary India

          

Brazil Cambodia Chile China Colombia Costa Rica Cuba Curaçao Dominican Republic Ecuador El Salvador

           

Israel Indonesia Jamaica Japan Kazakhstan Laos Mexico Myanmar New Zealand Nicaragua Paraguay Peru

Bayer factory in Leverkusen, Germany [edit]Subgroups and service companies Bayer AG comprises three subgroups and three services companies. The subgroups and service companies operate independently, led by the management holding company.[1] [edit]Bayer CropScience Bayer CropScience has products in crop protection and nonagricultural pest control. It also has activities in seeds and plant traits.[1] In 2002, Bayer AG acquired Aventis CropScience and fused it with their own agrochemicals division (Bayer Pflanzenschutz or "Crop Protection") to form Bayer

CropScience. The company is now one of the world's leading innovative crop science companies in the areas of crop protection (i.e. pesticides), nonagricultural pest control, seeds and plant biotechnology. In addition to conventional agrochemical business, it is involved in genetic engineering of food. The Belgian biotech company Plant Genetic Systems became part of the company by the acquisition of Aventis CropScience. Also in 2002, Bayer AG acquired the Dutch seed company Nunhems. In 2006, the U.S. Department of Agriculture announced that Bayer CropScience's LibertyLink genetically modified rice had contaminated the U.S. rice supply. Shortly after the public learned of the contamination, the E.U. banned imports of U.S. long-grain rice and the futures price plunged. In April 2010, a Lonoke County, Arkansas jury awarded a dozen farmers $48 million. The case is currently on appeal to the Arkansas Supreme Court. On July 1, 2011 Bayer CropScience agreed to a global settlement for up to $750 million. In a statement to the media Bayer said: "Although Bayer CropScience believes it acted responsibly in the handling of its biotech rice, the company considers it important to resolve the litigation so that it can move forward focused on its fundamental mission of providing innovative solutions to modern agriculture." [9] Bayer CropScience is involved in a joint project with Archer Daniels Midland Company and Daimler AG to develop jatropha as a biofuel.[10] [edit]Bayer HealthCare Bayer HealthCare is Bayer's pharmaceutical and medical products subgroup. It is involved in the research, development, manufacture and marketing of products that aim to improve the health of people and animals. Bayer HealthCare comprises a further four subdivisions: Bayer Schering Pharma, Bayer Consumer Care, Bayer Animal Health and Bayer Medical Care.[1] [edit]Bayer Pharma In 2007, Bayer took over Schering AG and formed Bayer Schering Pharma. The acquisition of Schering was the largest take-over in Bayer’s history. The name was changed to Bayer Pharma in 2011. Bayer Healthcare Pharmaceuticals is divided into two business units - General Medicine and Specialty Medicine. Women's healthcare is an example of a General Medicine business unit. Bayer Pharma produces the birth control pills Yaz and Yasmin. Both pills use a newer type

of progesterone hormone calleddrospirenone in combination with estrogen. Yaz is advertised as a treatment for premenstrual dysphoric disorder (PMDD) and moderate acne. Other key products include the cancer drug Nexavar, the multiple sclerosis drug Betaferon/Betaseron and the blood-clotting drug, Kogenate.[1] An example of a Specialty Medicine Business Unit is Diagnostic Imaging. Contrast agents from this unit helps play a crucial role in precise and early diagnosis and the selection of optimal treatment. Diagnostic imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound are used to make tissues and organs visible in their natural position inside the body along with contrast. Work is also focused on the development of tracers for positron emission tomography (PET). The PET tracer Florbetaben in Bayer's pipeline makes it possible to recognize beta Amyloid, one of the pathological hallmarks of Alzheimer's disease, with high accuracy very early on and while the patient is still alive. [edit]Bayer Consumer Care Bayer Consumer Care manages Bayer's OTC medicines portfolio. Key products include food supplements Redoxon and Berocca, and skincare products Bepanthen and Bepanthol.[1] [edit]Bayer Animal Health Bayer HealthCare's Animal Health Division is the maker of Advantage Multi (imidacloprid + moxidectin) Topical Solution for dogs and cats, Advantage flea control for cats and dogs and K9 Advantix, a flea, tick, and mosquito control product for dogs. Advantage Multi, K9 Advantix and Advantage are trademarks of Bayer. The division specializes in parasite control and prescription pharmaceuticals for dogs, cats, horses, and cattle. North American operation for the Animal Health Division are headquartered in Shawnee, Kansas. Bayer Animal Health is a division of Bayer HealthCare LLC, one of the world's leading healthcare companies. [edit]Bayer Medical Care Bayer Medical Care manages Bayer's medical devices portfolio. Key products include the blood glucose monitors Contour and Elite used in the management of diabetes.[1] [edit]Bayer Material Science Bayer MaterialScience is a supplier of high-tech polymers, and develops solutions for a broad range of applications relevant to everyday life.[1]

[edit]Bayer Business Services Located at the Bayer USA Headquarters in Robinson Township, Pennsylvania, a suburb of Pittsburgh, Bayer Business Services handles the information technology infrastructure and technical support aspect of Bayer USA and Bayer Canada. This is also the headquarters of the North American Service Desk, the central IT Help Desk for all of Bayer USA and Bayer Canada. [edit]Bayer Technology Services Bayer Technology Services is engaged in process development and in process and plant engineering, construction and optimization.[1] [edit]Currenta Currenta offers services for the chemical industry, including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.[1] [edit]Bayer 04 Leverkusen Main article: Bayer 04 Leverkusen In 1904, the company founded the sports club TuS 04 ("Turn- und Spielverein der Farbenfabriken vorm. Friedr. Bayer & Co."), later SV Bayer 04 ("Sportvereinigung Bayer 04 Leverkusen"), finally becoming TSV Bayer 04 Leverkusen ("Turn- und Sportverein") in 1984, generally, however, known simply as Bayer 04 Leverkusen. The club is best known for its football team, but has been involved in many other sports, including athletics, fencing, team handball, volleyball, boxing, and basketball. TSV Bayer 04 Leverkusen is one of the largest sports clubs in Germany. The company also supports similar clubs at other company sites, including Dormagen (particularly handball), Wuppertal (particularly volleyball), and Krefeld-Uerdingen (featuring another former Bundesliga football club, SC Bayer 05 Uerdingen, now KFC Uerdingen 05).[11] Due to cost factors, though, the company has decided to cut back its sponsorship of its top sports teams in most areas. The sponsoring agreements with first and seconddivision teams in basketball, team handball, and volleyball, as well as in olympic-level athletics and fencing, will be terminated in 2008 or 2010. Despite their many successes (multiple German national championships, as well as numerous Olympic medals), they are not considered to be valuable enough as a marketing tool in terms of their cost-tobenefit ratio. Only the very "telegenic" football team, whose marketing value is very high due the exposure in the media and the popularity of the sport itself, will continue to be

supported as in the past. General sponsoring of sport for youth and for handicapped people will also be continued as in the past.[12] [edit]Controversies [edit]Nazi chairman and aspirin discoverer It has been documented that aspirin compounds were successfully synthesized by various other scientists or groups thereof in the years between 1848–1869, long before Bayer's claims. This fact led to various patent litigations in the early 20th century.[13] In his book Aspirin: The Story of a Wonder Drug, author Diarmuid Jeffreys details the work of Arthur Eichengrün, the Bayer chemist who first found an aspirin formulation which was tolerable in thehuman stomach and did not have the unpleasant side effects of nausea and gastric pain. Eichengrün also invented the name aspirin and was the first person to use the new formulation to test its safety and efficacy. However, Eichengrün was excluded from the official version of Bayer's history in 1934 because of his Jewish origin. Instead, it was claimed by Bayer that aspirin was "discovered" by an "Aryan" scientist, Felix Hoffman, to alleviate the sufferings of his rheumatic father. Bayer AG publishes beliefs in the latter. Jeffreys also investigated Bayer's sponsorship of the experiments of the Nazi Josef Mengele. In 1956 Fritz ter Meer became chairman of Bayer's supervisory board. He was convicted at the Nuremberg trials for his part in carrying out experiments on human subjects at Auschwitz and imprisoned for five years. He was found "guilty of count two, plunder and spoliation, and count three, slavery and mass murder, sentenced to imprisonment for seven years."[14] Jeffreys' claims are widely reflected in other publications and official records,[15][16][17][18][19] [20] although they are also disputed in other publications.[21] [edit]Liberty Link rice In August 2006, it became apparent that the United States rice crop had been contaminated with unapproved genetically engineered Bayer CropScience rice.[22] More specifically, the genetically engineered rice has an herbicide-resistance trait. These forms of rice are commonly referred to among US rice growers as, Liberty Link rice 601 or LL 601. Approximately 100 varieties of rice are produced primarily in the following six states: Arkansas, Texas, Louisiana, Mississippi, Missouri, and California. The US rice crop is valued at approximately $1.88 billion annually. In 2005,

approximately 80% of the rice exported from the US was of the long grain variety, the variety contaminated.[citation needed] [edit]Imidacloprid Main article: Imidacloprid effects on bee population French and Nova Scotian beekeepers claim Bayer's seed treatment imidacloprid kills honeybees. France has since issued a provisional ban on the use of imidacloprid for corn seed treatment pending further action. A consortium of U.S. beekeepers filed a civil suit against Bayer CropScience for alleged losses. [edit]HIV infected blood products Main article: Contaminated haemophilia blood products A cite from http://www.haemophilia-litigation.com/, access date 31.05.2006: "After 1978, there were four major companies in the United States engaged in the manufacture, production and sale of Factor VIII and IX: Armour Pharmaceutical Company, Bayer Corporation and its Cutter Biological division, Baxter Healthcare and its Hyland Pharmaceutical division and Alpha Therapeutic Corporation, which have been or are defendants in certain lawsuits. The plaintiffs allege that the companies manufactured and sold blood factor products as beneficial "medicines" that were, in fact of likely to be contaminated with HIV and/or HCV. This resulted in the mass infection and/or deaths of thousands of haemophiliacs worldwide.[23] It is believed that three of these companies, Alpha, Baxter, and Cutter, recruited and paid donors from high risk populations, including prisoners (i.e. prison-based collections), intravenous drug users, and plasma centers with predominantly homosexual donors, esp. in cities with large populations thereof, to obtain blood plasma used for the production of Factor VIII and IX. Plaintiffs allege that these companies failed to exclude donors, as mandated by federal law, with a history of viral hepatitis. Such testing could have substantially reduced the likelihood of plasma containing HIVand/ or HCV entering plasma pools."[24][25]
[26]

[edit]Baycol After 52 deaths were blamed on an alleged side effect of Bayer's anticholesterol drug Baycol, its manufacture and sale were discontinued in

2001. The side effect was rhabdomyolysis, causing renal failure, which occurred with a tenfold greater frequency in patients treated with Baycol in comparison to those prescribed alternate medications of the statin class.[27] [edit]Methyl parathion poisoning case In October 2001, Bayer was taken to court after 24 children in the remote Andean village of Tauccamarca, Peru were killed and 18 severely poisoned when they drank a powdered milk substitutecontaminated with the insecticide methyl parathion. A Peruvian Congressional Subcommittee found significant evidence of criminal responsibility by Bayer and the Peruvian Ministry of Agriculture.[28] [edit]Medicaid reimbursement In January 2001, Bayer agreed to pay $14 million to the United States and 45 states to settle allegations under the federal False Claims Act that the company caused physicians and other health care providers to submit fraudulently inflated reimbursement claims to Medicaid.[29] [edit]2006 Trasylol safety advisory In September 2006, Bayer was faulted by the FDA for not revealing during testimony the existence of a commissioned retrospective study of 67,000 patients, 30,000 of whom received Trasylol and the rest other antifibrinolytics. The study concluded Trasylol carried greater risks. The FDA was alerted to the study by one of the researchers involved. Although the FDA issued a statement of concern, they did not change their recommendation that the drug may benefit certain patients. In a Public Health Advisory Update dated October 3, 2006, the FDA recommended "physicians consider limiting Trasylol use to those situations in which the clinical benefit of reduced blood loss is necessary to medical management and outweighs the potential risks" and carefully monitor patients.[30] The FDA took Trasylol off the market on November 5, 2007.[31] [edit]Prostate cancer claims In October 2009, the Center for Science in the Public Interest sued Bayer for "falsely claiming that the selenium in Men's One-A-Day multivitamins might reduce the risk of prostate cancer." [32] [edit]Neonicotinoid pesticides

In December 2010, a leaked memo from the EPA’s Environmental Fate and Effects Division asserted “Clothianidin’s (Bayer's neonicotinoid pesticide) major risk concern is to non-target insects (that is, honey bees). Exposure through contaminated pollen and nectar and potential toxic effects therefore remain an uncertainty for pollinators.”[33][34][35] In January 2011, Avaaz.org launched an online petition to ban neonicotinoid pesticides.
[36]

[edit]Chemical accidents On August 28, 2008, an explosion occurred at the Bayer CropScience facility at Institute, West Virginia. A runaway reaction ruptured a tank and the resulting explosion killed two employees. The ruptured tank was close to a methyl isocyanate tank which was undamaged by the explosion.[37] [edit]Awards and recognition In October 2008, Bayer's Canadian division was named one of "Canada's Top 100 Employers" by Mediacorp Canada Inc., and was featured in Maclean's news magazine. Later that month, the Canadian division was also named one of Greater Toronto's Top Employers, which was announced by the Toronto Star newspaper.[38] Bayer USA was given a score of 85 (out of 100) in the Human Rights Campaign's 2011 Corporate Equality Index, a measure of gay and lesbian workplace equality.[39] [edit]

Bloomberg L.P. From Wikipedia, the free encyclopedia Bloomberg L.P.

Type Industry Founded Founder(s)

Limited partnership Financial services October 1, 1981[1] Michael Bloomberg, Thomas Secunda

Headquarters Bloomberg Tower, Manhattan, New York City, New York, U.S. Number of locations Key people 200 offices (June 2010)[2]

Peter Grauer (Chairman) Dan Doctoroff (President) US$ 6.9 billion (projected 2010) Michael Bloomberg (88%)
[3]

Revenue

Owner(s)

Employees Website

13,000 (Dec 2010)[2] Bloomberg.com

Bloomberg broadcasting studio in London Bloomberg L.P. is an American privately held financial software, media, and data company. Bloomberg makes up one third of the $16 billion global financial data market[4] with estimated revenue of $6.9 billion.[5] Bloomberg L.P. was founded by Michael Bloomberg (current Mayor of New York City) with the help of Thomas Secunda, Duncan MacMillan, and Charles Zegar in 1981 and a 30% ownership investment by Merrill Lynch.[6] The company provides financial software tools such as analytics and equity trading platform, data services and news to financial companies and organizations around the world through the Bloomberg Terminal (via its Bloomberg Professional Service),[7] its core money-generating product. Many customers use only a small fraction of the machine's 30,146 functions.[8] Bloomberg L.P. has grown to include a global news service, including television, radio, the Internetand printed publications. Its current headquarters are located at the Bloomberg Tower, 731 Lexington Avenue in Midtown Manhattan, New York City. The building is also known asOne Beacon Court for the lighted rectangular beacon that caps the tower and the paved courtyard at the ground level.[9] Bloomberg L.P. was formed as a Delaware Limited Partnership in 1981 and has been in business since 1983. Michael Bloomberg owns 85% of the partnership. Bloomberg's core business is leasing terminals to subscribers. It also runs Bloomberg Television, a financial Television_network, and a business radio station WBBR in New York City at a loss. Bloomberg's revenue for 2009 was estimated at $6.25 billion. Based on that estimate, the new projections would push revenue to nearly $6.9 billion for 2010. [10] There are currently over 300,000 Bloomberg Terminal subscribers worldwide. Its competitors include SNL Financial, Interactive Data Corporation, Thomson

Reuters, Capital IQ, Dow Jones Newswires, FactSet Research Systems and smaller companies such as New York Financial Press. In late 1996 Bloomberg bought back one-third of Merrill Lynch's 30 percent stake in his company for $200 million[11] valuing the company at $2.0 billion. In July 2008, Merrill Lynch agreed to sell its 20% stake in the firm back to Bloomberg, for a reported $4.43 billion, valuing the firm at approximately $22.5 billion.[12][13] History, services and products In 1981, Salomon Brothers was acquired, and Michael Bloomberg, a general partner, was given a $10 million partnership settlement.[14] Using this money, Bloomberg went on to set up a company named Innovative Market Systems. In 1982, Merrill Lynch became the new company's first customer, installing 22Market Master terminals and investing $30 million in the company.[15][16] [17] In 1986, the company was renamed Bloomberg L.P. and by 1988, 5000 terminals had been installed.[18] Within a few years, ancillary products including Bloomberg Tradebook (a trading platform), the Bloomberg Messaging Service, and the Bloomberg newswire were launched. In addition to its financial services offerings, Bloomberg launched its news services division in 1990. Bloomberg News (originally known as Bloomberg Business News) has over 2,000 employees and 145 bureaus around the world, producing more than 5,000 stories daily.[19] It now provides information to approximately 350 newspapers and magazines worldwide, including The Economist, The New York Times and USA Today.
[20]

To run for the position of Mayor of New York against Democrat Mark Green in 2001, Mike Bloomberg gave up his position of CEO at Bloomberg and appointed Lex Fenwick as CEO in his stead.[21]Daniel Doctoroff, former deputy mayor in the Bloomberg administration, now serves as president.[22] Peter Grauer is the chairman. In September 2007, the Equal Employment Opportunity Commission filed a class-action lawsuit on behalf of more than 80 female employees, who argue Bloomberg L.P. engaged in a pattern ofdiscrimination against pregnant women who took maternity leave.[23] The suit alleges that 'Michael Bloomberg is responsible for the creation of the systemic, top-down culture of discrimination' at the company.[23] A Bloomberg L.P. spokeswoman said: 'We are confident that once all the facts come out they will demonstrate that the claims have no merit.'[23]

Bloomberg News was the subject of an investigative feature by Vanity Fair in December 2008.[24] In 2009, Bloomberg acquired BusinessWeek, a consumer oriented business magazine and Web property, from McGraw-Hill;[25] and New Energy Finance, now called Bloomberg New Energy Finance, a data company focused on energy investment and carbon markets research based in the U.K.[26] The same year, The New York Times covered Bloomberg's growth and aspirations in a full-length media section feature.[27] Bloomberg New Energy Finance is a specialist provider of financial information and research to the renewable energy technology sector and its investors worldwide.[28] [edit]Corporate governance As of July 2010, members of the board of directors of Bloomberg include: Peter Grauer, Daniel Doctoroff, Thomas Secunda, Arthur Levitt, Jane Bryant Quinn, Frank Savage, Richard DeScherer andHugh Lowenstein.[29] [edit]Litigation against Board of Governors of Federal Reserve System Bloomberg L.P. News brought a lawsuit against the Board of Governors of the Federal Reserve System to force the Board to reveal the identities of firms for which it has provided guarantees.[30]Bloomberg, L.P. won at the trial court level.[31] On August 24, 2010, the United States Court of Appeals[clarification needed what circuit?] refused to revisit a request by the Fed to review an earlier Court of Appeals decision requiring the agency to release the records.[32] On August 27, 2010, the court agreed to delay implementation of the ruling until Oct. 19 so that the Fed may appeal to the Supreme Court.[33] As of September 2010 the Fed has indicated it will do so.[34]

James Walter Thompson From Wikipedia, the free encyclopedia James Walter Thompson (28 October 1847 – 16 October 1928) was the namesake of the JWT advertising agency and a pioneer of many advertising techniques.[1] He was born in Pittsfield,Massachusetts. In 1868, James Walter Thompson, age 24, completed service in the U.S. Marines Corps, on the USS Saratoga, and moved to New York to find employment. Carlton hired

Thompson as a bookkeeper. Eventually Thompson found that soliciting and sales were much more profitable and he became a very effective salesman for the small company. In 1877, Thompson bought the agency for $500 and renamed it J. Walter Thompson Company. Notably, Thompson paid $800 for the Carlton and Smith furniture in the same transaction. Realizing that he could sell more space if the company provided the service of developing content for advertisers, Thompson hired writers and artists to form the first known Creative Department in an advertising agency. He is credited as the "father of modern magazine advertising" in the US. Mr. Thompson, having served on the USS Saratoga in the Civil War, was a passionate sailor. He owned a variety of vessels, including a seagoing houseboat, a steam yacht, (Stella). He headed the NY Yacht Club, for which his title as Commodore and his portrait became famous within the Company. He lived at 11 East 68th Street in Manhattan. The J. Walter Thompson Company was incorporated in 1896. In 1899: J. Walter Thompson opened an office in London. An avid traveler, Mr. Thompson went abroad nearly every summer for 20 years, and rarely came back without important accounts. He saw New York as ‘the flagship’ office for a company with no geographical restrictions. “It has no limitations. Any spot on earth where goods are to be sold by advertising is inside the fence of the Thompson field,” said Thomspon.[2] In 1900, JWT published a house ad explaining ‘trademark advertising’. This was the first known commercial explanation of what we now know as ‘branding’. Mr. Thompson soon became known for his philosophy of ‘drawing a straight line between the manufacturer and the consumer.’ In 1916, Stanley Resor and several partners bought the Company from the aging James Walter Thompson for $500,000. In 1930, a letter addressed to Mr. Thompson arrived from soon to be president Franklin D. Roosevelt asking for a job for his son Elliott, guaranteeing ‘he has a perfectly good mind.’ Mr. Thompson had died in 1928, and Elliott never did work for JWT. (JWT’s mother was a distant cousin of FDR). In 1937, J. Walter Thompson produced the first All Colored Program for Fleischmanns Yeast which starred Louis Armstrong. In the confines of a script, it was needed for Armstrong to use minstrel dialect and use a weekly “sketch” by two comic characters,

Eddie Green and Gee Gee James, who were in the stereotypes of minstrel characters. However, Armstrong refused to speak this dialogue, changing lines into standard English as he read them over the air. He eventually gained a reputation of being difficult to work with. The show was canceled after only six weeks.[3] Thompson is responsible for some enduring brand images in popular culture, like the Rock of Gibraltar used for the Prudential Insurance Company. Today, JWT is one of the largest advertising agencies in the United States and the fourth-biggest in the world. It is one of the key companies of Sir Martin Sorrell's WPP Group (NASDAQ:WPPGY) and is headquartered in New York. The global agency is led by Worldwide Chairman and Global CEO Bob Jeffrey who took over the role in 1998. [4] JWT was named Adweek magazine's 2009 "Global Agency of the Year."[5] JWT's remit is to create ideas people want to spend time with.

JWT ADD AGENCY IN INDIA